Erratum: E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice (PLoS Pathogens (2011) 7:7 (e1002125) DOI: 10.1371/journal.ppat.1002125);E6 and E7 from beta hpv38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice

PLoS Pathogens

Volumn 7, Issue 7, 2011, Pages

  Viarisio, Daniele ^a   Mueller Decker, Karin ^a   Kloz, Ulrich ^a   Aengeneyndt, Birgit ^a   Kopp Schneider, Annette ^a   Gröne, Hermann Josef ^a   Gheit, Tarik ^b   Flechtenmacher, Christa ^c   Gissmann, Lutz ^a,d   Tommasino, Massimo ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

12 0 TETRADECANOYLPHORBOL 13 ACETATE; CYTOKERATIN 14; DIMETHYLBENZ[A]ANTHRACENE; ONCOPROTEIN; PROTEIN E6; PROTEIN E7; PROTEIN P21; UNCLASSIFIED DRUG; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PHORBOL 13 ACETATE 12 MYRISTATE;

ACTINIC KERATOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 38; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION; VIRUS ONCOGENE; WART VIRUS; WILD TYPE; ALPHAPAPILLOMAVIRUS; ANIMAL; BIOSYNTHESIS; GENETICS; KERATINOCYTE; METABOLISM; PAPILLOMAVIRUS INFECTION; PATHOLOGY; SKIN TUMOR; VIROLOGY;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; MUS; MUS MUSCULUS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ALPHAPAPILLOMAVIRUS; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPIDERMIS; HUMANS; KERATINOCYTES; KERATOSIS, ACTINIC; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; ULTRAVIOLET RAYS;

EID: 79960944402     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006005     Document Type: Erratum

References (40)

1. Pisani P, Bray F, Parkin DM, (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97: 72-81.
2. Ananthaswamy HN, Loughlin SM, Cox P, Evans RL, Ullrich SE, et al. (1997) Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat Med 3: 510-514.
3. Armstrong BK, Kricker A, (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63: 8-18.
4. Preston DS, Stern RS, (1992) Nonmelanoma cancers of the skin. N Engl J Med 327: 1649-1662.
5. Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC, (1984) Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1: 702-705.
6. Kiviat NB, (1999) Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Semin Cancer Biol 9: 397-403.
7. Walder BK, Jeremy D, Charlesworth JA, Macdonald GJ, Pussell BA, et al. (1976) The skin and immunosuppression. Australas J Dermatol 17: 94-97.
8. Walder BK, Robertson MR, Jeremy D, (1971) Skin cancer and immunosuppression. Lancet 2: 1282-1283.
9. Pfister H, (2003) Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31: 52-56.
10. Bouvard V, Gabet AS, Accardi R, Sylla SB, Tommasino M, (2006) The cutaneous human papillomavirus types and non-melanoma-skin cancer. Papillomavirus Research: From Natural History to Vaccine and Beyond Caister Academic Press, Norfolk, UK pp. 269-277.
11. Berkhout RJ, Bouwes Bavinck JN, Ter Schegget J, (2000) Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 38: 2087-2096.
12. de Jong-Tieben LM, Berkhout RJ, Smits HL, Bouwes Bavinck JN, Vermeer BJ, et al. (1995) High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 105: 367-371.
13. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, et al. (2000) Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61: 289-97.
14. Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, et al. (2008) Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 17: 189-195.
15. Waterboer T, Abeni D, Sampogna F, Rother A, Masini C, et al. (2008) Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol 159: 457-459.
16. Casabonne D, Michael KM, Waterboer T, Pawlita M, Forslund O, et al. (2007) A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121: 1862-1868.
17. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, et al. (2006) Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98: 389-395.
18. Karagas MR, Waterboer T, Li Z, Nelson HH, Michael KM, et al. (2010) Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 341: c2986.
19. Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, et al. (2010) Multicenter Study of the Association between Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma. Cancer Res 70: 9777-9786.
20. Jackson S, Harwood C, Thomas M, Banks L, Storey A, (2000) Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14: 3065-3073.
21. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA, (2008) E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol 82: 10408-10417.
22. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, et al. (2003) The E6 and E7 proteins of cutaneous human papillomavirus type 38 display transforming properties. J Virol 77: 2195-2206.
23. Gabet AS, Accardi R, Bellopede A, Popp S, Boukamp P, et al. (2008) Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. Faseb J 22: 622-632.
24. Accardi R, Dong W, Smet A, Cui R, Hautefeuille A, et al. (2006) Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep 7: 334-340.
25. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, et al. (2005) Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65: 1394-1400.
26. Marcuzzi GP, Hufbauer M, Kasper HU, Weissenborn SJ, Smola S, et al. (2009) Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 90: 2855-2864.
27. Michel A, Kopp-Schneider A, Zentgraf H, Gruber AD, de Villiers EM, (2006) E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 80: 11153-11164.
28. Dong W, Kloz U, Accardi R, Caldeira S, Tong WM, et al. (2005) Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 79: 14899-14908.
29. Fuchs E, (1995) Keratins and the skin. Annu Rev Cell Dev Biol 11: 123-153.
30. Helfrich I, Chen M, Schmidt R, Furstenberger G, Kopp-Schneider A, et al. (2004) Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis. J Virol 78: 4797-805.
31. Song S, Liem A, Miller JA, Lambert PF, (2000) Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 267: 141-150.
32. Bedard KM, Underbrink MP, Howie HL, Galloway DA, (2008) The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol 82: 3894-3902.
33. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B, et al. (2010) The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 40: 1-13.
34. Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, et al. (2005) Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 125: 93-97.
35. Iftner T, Bierfelder S, Csapo Z, Pfister H, (1988) Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J Virol 62: 3655-3661.
36. Yamashita T, Segawa K, Fujinaga Y, Nishikawa T, Fujinaga K, (1993) Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Oncogene 8: 2433-2441.
37. Schmitt A, Harry JB, Rapp B, Wettstein FO, Iftner T, (1994) Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol 68: 7051-7059.
38. Iftner T, Fuchs PG, Pfister H, (1989) Two independently transforming functions of human papillomavirus 8. Curr Top Microbiol Immunol 144: 167-173.
39. Pfefferle R, Marcuzzi GP, Akgul B, Kasper HU, Schulze F, et al. (2008) The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J Invest Dermatol 128: 2310-2315.
40. Auewarakul P, Gissmann L, Cidarregui A, (1994) Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol Cell Biol 14: 8250-8258.